I saw where my thought was confirmed on how GNBT could use the NGIO shares they own. “While Generex owns over 90% of our common stock, going forward, we will rely both on financing from third parties and from Generex, which may sell shares of our common stock, to fund our operations, development, and other activities.” Thanks TC for your work highlighting the NGIO 10-12G/A changes, I probably would have missed this without your effort.
So I wonder if the NGIO IPO will be with GNBT shares or sold from the 350 million treasury reserve. For a successful launch, NGIO needs an attractive value (like CVAC). Good results from the Ii-key peptide covid-19 tests should do the trick.
Does anyone know if this has ever been done before; a public company creates a wholly private company, gives 10% away as a shareholder dividend, then takes the private company public while holding 90% (minus IPO shares) of the outstanding stock? If so, please post the company, I would like to see how it turned out. But if this has never been done before, then maybe this is why there has be delays and confusion with the SEC trying to make sure it is done correct and legal. And if everything is successful, maybe the persons who saw corporate ineptitude might see things from a different angle.
Question: If a public held bank had say a pile of gold in their vault worth $100 million and there were 10 million outstanding shares, wouldn’t each share have to be worth at least $10? And if this is true, then after NGIO goes public, wouldn’t each GNBT outstanding share have to be worth at least 4 NGIO shares? As of today; approximately 360 million NGIO outstanding shares are held by 80 million GNBT outstanding shareholders.
I see the NGIO IPO as a rocket launch with us the investors as the payload. With a real rocket launch there is a prescribed countdown with countless safety checks, and sometimes pauses in the countdown for addition safety measures. What I don’t want to see in the NGIO launch, in a haste to press the proverbial “red” button, something being overlooked, even seemingly insignificant, like say an O-Ring (Space Shuttle Challenger January 28, 1986). Don’t want things to blow-up in midair and not achieve orbit.
So I wonder if the NGIO IPO will be with GNBT shares or sold from the 350 million treasury reserve. For a successful launch, NGIO needs an attractive value (like CVAC). Good results from the Ii-key peptide covid-19 tests should do the trick.
Does anyone know if this has ever been done before; a public company creates a wholly private company, gives 10% away as a shareholder dividend, then takes the private company public while holding 90% (minus IPO shares) of the outstanding stock? If so, please post the company, I would like to see how it turned out. But if this has never been done before, then maybe this is why there has be delays and confusion with the SEC trying to make sure it is done correct and legal. And if everything is successful, maybe the persons who saw corporate ineptitude might see things from a different angle.
Question: If a public held bank had say a pile of gold in their vault worth $100 million and there were 10 million outstanding shares, wouldn’t each share have to be worth at least $10? And if this is true, then after NGIO goes public, wouldn’t each GNBT outstanding share have to be worth at least 4 NGIO shares? As of today; approximately 360 million NGIO outstanding shares are held by 80 million GNBT outstanding shareholders.
I see the NGIO IPO as a rocket launch with us the investors as the payload. With a real rocket launch there is a prescribed countdown with countless safety checks, and sometimes pauses in the countdown for addition safety measures. What I don’t want to see in the NGIO launch, in a haste to press the proverbial “red” button, something being overlooked, even seemingly insignificant, like say an O-Ring (Space Shuttle Challenger January 28, 1986). Don’t want things to blow-up in midair and not achieve orbit.
4
